The University of Chicago Header Logo

Connection

Fredric L. Coe to Glycoproteins

Back to Details
This is a "connection" page, showing publications Fredric L. Coe has written about Glycoproteins.
Fredric L. Coe
Connection Strength
1.140
Glycoproteins
  1. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Miner Electrolyte Metab. 1994; 20(6):378-84.
    View in: PubMed
    Score: 0.108
  2. Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo. Cancer Res. 1992 Mar 15; 52(6):1573-9.
    View in: PubMed
    Score: 0.096
  3. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals. Am J Physiol. 1991 Nov; 261(5 Pt 2):F824-30.
    View in: PubMed
    Score: 0.093
  4. Inhibitors within the nephron. Am J Kidney Dis. 1991 Apr; 17(4):407-13.
    View in: PubMed
    Score: 0.090
  5. Isolation of nephrocalcin from kidney tissue of nine vertebrate species. Am J Physiol. 1991 Feb; 260(2 Pt 2):F243-8.
    View in: PubMed
    Score: 0.089
  6. Evidence that mouse renal proximal tubule cells produce nephrocalcin. Am J Physiol. 1989 Sep; 257(3 Pt 2):F390-8.
    View in: PubMed
    Score: 0.080
  7. Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer. FEBS Lett. 1989 Jul 03; 250(2):187-90.
    View in: PubMed
    Score: 0.079
  8. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol. 1989 Jul; 257(1 Pt 2):F99-106.
    View in: PubMed
    Score: 0.079
  9. Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol. 1988 Dec; 255(6 Pt 2):F1197-205.
    View in: PubMed
    Score: 0.076
  10. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. J Clin Invest. 1987 Jun; 79(6):1782-7.
    View in: PubMed
    Score: 0.069
  11. Glycoprotein calcium oxalate crystal growth inhibitor in urine. Miner Electrolyte Metab. 1987; 13(4):267-72.
    View in: PubMed
    Score: 0.067
  12. Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest. 1985 Oct; 76(4):1455-62.
    View in: PubMed
    Score: 0.061
  13. Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine. Am J Physiol. 1984 Nov; 247(5 Pt 2):F765-72.
    View in: PubMed
    Score: 0.057
  14. Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. Kidney Int. 1990 Oct; 38(4):625-31.
    View in: PubMed
    Score: 0.022
  15. A new spectrophotometric method for measuring calcium oxalate monohydrate crystal aggregation in the absence of supersaturation: inhibitory effects of urinary glycoproteins. Urol Res. 1989; 17(3):149-50.
    View in: PubMed
    Score: 0.019
  16. Immunochemistry of urinary calcium oxalate crystal growth inhibitor (CGI). Kidney Int. 1986 Apr; 29(4):829-33.
    View in: PubMed
    Score: 0.016
  17. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis. Trans Assoc Am Physicians. 1985; 98:281-9.
    View in: PubMed
    Score: 0.015
  18. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem. 1983 Oct 25; 258(20):12594-600.
    View in: PubMed
    Score: 0.013
  19. Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium. J Biol Chem. 1981 Apr 25; 256(8):3936-44.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.